595 filings
S-8
ELTP
Elite Pharmaceuticals Inc
28 Mar 24
Registration of securities for employees
4:06pm
S-8
ELTP
Elite Pharmaceuticals Inc
28 Mar 24
Registration of securities for employees
4:06pm
8-K
ELTP
Elite Pharmaceuticals Inc
14 Feb 24
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024
4:55pm
10-Q
2024 Q3
ELTP
Elite Pharmaceuticals Inc
Quarterly report
14 Feb 24
4:06pm
8-K
ELTP
Elite Pharmaceuticals Inc
26 Dec 23
Regulation FD Disclosure
4:20pm
8-K
39ek yb5e7cdv5
12 Dec 23
Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR® to Marketing Partner Prasco, LLC
4:20pm
8-K
our zw9r12
14 Nov 23
Results of Operations and Financial Condition
5:22pm
8-K
fzgeimh nadvu
25 Sep 23
Regulation FD Disclosure
4:15pm
8-K
opg29dsa96eyt8
7 Sep 23
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
4:05pm
8-K
g1rnu3 713fdic
14 Aug 23
Elite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024
5:30pm
8-K
n0vwy2pra8k1a2
17 Jul 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K
85ge6xe1csmb2i 73
29 Jun 23
Results of Operations and Financial Condition
5:15pm
8-K
2em0cr7jkkfqadtl
3 May 23
Elite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officer
4:15pm
8-K
7u7n0343nezxjm1ecty
20 Apr 23
Regulation FD Disclosure
10:05am
8-K
m0h5wqw
28 Feb 23
Departure of Directors or Certain Officers
4:36pm
8-K
wt01i0x czxdq7kei0
14 Feb 23
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023
5:10pm